Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amitabh Chandra

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
The American Economic Review|November 10, 2017
The Consequences of the Growth of Health Insurance PremiumsKatherine Baicker, Amitabh Chandra
The New England Journal of Medicine|July 13, 2017
The Economics of Indication-Based Drug PricingAmitabh Chandra, Craig Garthwaite
The New England Journal of Medicine|September 1, 2025
The Corporatization Deal - Health Care, Investors, and the Profit PriorityAmitabh Chandra, Mark Shepard
The American Economic Review|October 27, 2017
The Productivity of Physician Specialization: Evidence from the Medicare ProgramKatherine Baicker, Amitabh Chandra
The Quarterly Journal of Economics|December 28, 2020
IDENTIFYING SOURCES OF INEFFICIENCY IN HEALTHCAREAmitabh Chandra, Douglas O Staiger
JAMA|January 1, 2016
Competition and Biosimilar Products--ReplyAmitabh Chandra, Jacqueline Vanderpuye-Orgle
Social Science & Medicine (1982)|August 10, 2010
Rising up with shoe leather? A comment on Fair Society, Healthy Lives (the Marmot Review)Amitabh Chandra, Tom S Vogl
The New England Journal of Medicine|April 13, 2017
An FDA Commissioner for the 21st CenturyAmitabh Chandra, Rachel E Sachs
The Journal of Political Economy|April 18, 2008
PRODUCTIVITY SPILLOVERS IN HEALTHCARE: EVIDENCE FROM THE TREATMENT OF HEART ATTACKSAmitabh Chandra, Douglas O Staiger
JAMA|July 22, 2015
Competition in the Age of BiosimilarsAmitabh Chandra, Jacqueline Vanderpuye-Orgle
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
The American Economic Review|November 10, 2017
The Consequences of the Growth of Health Insurance PremiumsKatherine Baicker, Amitabh Chandra
The New England Journal of Medicine|July 13, 2017
The Economics of Indication-Based Drug PricingAmitabh Chandra, Craig Garthwaite
The New England Journal of Medicine|September 1, 2025
The Corporatization Deal - Health Care, Investors, and the Profit PriorityAmitabh Chandra, Mark Shepard
The American Economic Review|October 27, 2017
The Productivity of Physician Specialization: Evidence from the Medicare ProgramKatherine Baicker, Amitabh Chandra
The Quarterly Journal of Economics|December 28, 2020
IDENTIFYING SOURCES OF INEFFICIENCY IN HEALTHCAREAmitabh Chandra, Douglas O Staiger
JAMA|January 1, 2016
Competition and Biosimilar Products--ReplyAmitabh Chandra, Jacqueline Vanderpuye-Orgle
Social Science & Medicine (1982)|August 10, 2010
Rising up with shoe leather? A comment on Fair Society, Healthy Lives (the Marmot Review)Amitabh Chandra, Tom S Vogl
The New England Journal of Medicine|April 13, 2017
An FDA Commissioner for the 21st CenturyAmitabh Chandra, Rachel E Sachs
The Journal of Political Economy|April 18, 2008
PRODUCTIVITY SPILLOVERS IN HEALTHCARE: EVIDENCE FROM THE TREATMENT OF HEART ATTACKSAmitabh Chandra, Douglas O Staiger
JAMA|July 22, 2015
Competition in the Age of BiosimilarsAmitabh Chandra, Jacqueline Vanderpuye-Orgle
Pageof 12